Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Bupropion Hydroxylation as a Selective Marker of Rat CYP2B1 Catalytic Activity

Dumrongsak Pekthong, Coraline Desbans, Hélène Martin and Lysiane Richert
Drug Metabolism and Disposition January 2012, 40 (1) 32-38; DOI: https://doi.org/10.1124/dmd.111.041368
Dumrongsak Pekthong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Coraline Desbans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hélène Martin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lysiane Richert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 40 no. 1 32-38
DOI 
https://doi.org/10.1124/dmd.111.041368
PubMed 
21965622

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received June 24, 2011
  • Accepted September 30, 2011
  • Published online December 16, 2011.

Article Versions

  • Earlier version (September 30, 2011 - 08:35).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Dumrongsak Pekthong,
  2. Coraline Desbans,
  3. Hélène Martin and
  4. Lysiane Richert
  1. KaLy-Cell, Bioparc, Illkirch, France (D.P., C.D., L.R.); Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand (D.P.); and Laboratoire de Toxicologie Cellulaire, Faculté de Médecine et de Pharmacie, Université de Franche-Comté, Besançon, France (H.M., L.R.)
  1. Address correspondence to:
    Lysiane Richert, KaLy-Cell, Bioparc, Boulevard Sébastien Brant, 67400 Illkirch Cedex, France. E-mail: l.richert{at}kaly-cell.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to January 2023

AbstractFullPdf
Aug 20172155
Sep 201721712
Oct 201712412
Nov 201722015
Dec 201703836
Jan 201803216
Feb 201832068
Mar 201851039
Apr 201805616
May 20180393
Jun 20184476
Jul 20181337
Aug 20180155
Sep 20181143
Oct 20186388
Nov 20180618
Dec 201850112
Jan 20196323
Feb 20194910
Mar 20192112
Apr 201917011
May 2019434
Jun 2019912
Jul 2019719
Aug 20191432
Oct 20191612
Nov 20192302
Dec 20192312
Jan 20201922
Feb 2020921
Mar 2020905
May 20201000
Jun 2020810
Jul 2020601
Aug 2020202
Sep 20201024
Oct 20201225
Nov 2020424
Dec 20201411
Jan 20211366
Feb 20212145
Mar 20211111
Apr 20211620
May 20211620
Jun 2021431
Jul 20211112
Aug 20211730
Sep 20211220
Oct 20211021
Nov 20211234
Dec 20212511
Jan 2022711
Feb 20221923
Mar 2022711
Apr 20221022
May 20221210
Jun 20221620
Jul 202218113
Aug 20221524
Sep 2022611
Oct 20221934
Nov 20222012
Dec 20222110
Jan 20231661

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 40 (1)
Drug Metabolism and Disposition
Vol. 40, Issue 1
1 Jan 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Bupropion Hydroxylation as a Selective Marker of Rat CYP2B1 Catalytic Activity
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

BUPROPION HYDROXYLATION A MARKER OF RAT CYP2B1 ACTIVITY

Dumrongsak Pekthong, Coraline Desbans, Hélène Martin and Lysiane Richert
Drug Metabolism and Disposition January 1, 2012, 40 (1) 32-38; DOI: https://doi.org/10.1124/dmd.111.041368

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

BUPROPION HYDROXYLATION A MARKER OF RAT CYP2B1 ACTIVITY

Dumrongsak Pekthong, Coraline Desbans, Hélène Martin and Lysiane Richert
Drug Metabolism and Disposition January 1, 2012, 40 (1) 32-38; DOI: https://doi.org/10.1124/dmd.111.041368
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Warfarin PBPK Model with TMDD Mechanism
  • Identification of payload-containing catabolites of ADCs
  • PK Interactions of Licorice with Cytochrome P450s
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics